Isomark’s team is an enthusiastic, talented group of individuals working in a tightly knit, supportive and flexible environment.
Their mission is to become the industry gold standard for early disease detection, and making their patented green technology available to customers.
Team members
Fariba Assadi-Porter
PhD, Founder and CEO, Board Director
Emeritus biochemist from UW-Madison with 25 years of research expertise in metabolism, stable isotopes, breath studies, metabolomics and protein chemistry through NIH, NSF and private funded programs. As a PI or Co-PI, Dr. Assadi-Porter brought more than $14 million in research funds over the past ten years in high impact, high risks competitions. She has 15 years of entrepreneurial and business experience, and business certification programs through D2P and UP-Start entrepreneurial programs at UW-Madison and School of Business.
Dan Butz
PhD, Co-founder and CSO
Chief Scientist and principal investigator with a focus on early detection of disease. Leading a dynamic multidisciplinary team of key opinion leaders, scientists, administrators, intensive care specialists, clinical researchers, and engineers Dr. Butz drove development of both the Canary Infection Monitor and Canary-AG from concept to commercial ready.
